newsfilter
← Latest News
GlobeNewswire·

ObsEva to Present at the H.C. Wainwright BioConnect 2022 Conference

GENEVA, Switzerland January 3, 2022 – ObsEva SA (NASDAQ:OBSV, SIX: OBSN))), a biopharmaceutical company developing and commercializing novel therapies to improve women's reproductive health, today announced that Company Management will provide a corpor